ArticleJournal of cancer research and clinical oncology2023

Real-world progression-free survival (rwPFS) and the impact of PD-L1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapy.

J Nicholas Bodor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.